Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics

被引:16
作者
Chang, Kyong-Mi [1 ,2 ]
Liu, Mengfei [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Philadelphia Corporal Michael J Crescenz VA Med C, Philadelphia, PA 19104 USA
关键词
REGULATORY T-CELLS; CHIMERIC ANTIGEN RECEPTOR; SENSOR RIG-I; VIRAL CLEARANCE; VIRUS INFECTION; PEGINTERFERON ALPHA-2A; METABOLIC-REGULATION; LAMIVUDINE TREATMENT; COMBINATION THERAPY; PROGRAMMED DEATH-1;
D O I
10.1016/j.coph.2016.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatitis B virus (HBV) evades, subverts, activates and regulates host immune components, thereby impacting its natural history and disease pathogenesis. Recent advances in our understanding of immune interactions in chronic viral infection and tumor therapy are applicable to chronic hepatitis B (CHB). With recent successes of tumor immunotherapy, there is a renewed interest in exploring immunotherapeutics in achieving sustained and functional cure of chronic hepatitis B. In this review, we discuss aspects of host innate and adaptive immune regulatory and pathogenic responses relevant for HBV infection. We also highlight several immune modulatory approaches in clinical development to treat CHB.
引用
收藏
页码:93 / 105
页数:13
相关论文
共 148 条
[1]  
ANDO K, 1994, J IMMUNOL, V152, P3245
[2]  
ARAKI K, 1982, CLIN EXP IMMUNOL, V47, P520
[3]   The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection [J].
Asabe, Shinichi ;
Wieland, Stefan F. ;
Chattopadhyay, Pratip K. ;
Roederer, Mario ;
Engle, Ronald E. ;
Purcell, Robert H. ;
Chisari, Francis V. .
JOURNAL OF VIROLOGY, 2009, 83 (19) :9652-9662
[4]   Metabolic regulation of immune responses: therapeutic opportunities [J].
Assmann, Nadine ;
Finlay, David K. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (06) :2031-2039
[5]   Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C [J].
Baumert, Thomas F. ;
Roesler, Christine ;
Malim, Michael H. ;
von Weizaecker, Fritz .
HEPATOLOGY, 2007, 46 (03) :682-689
[6]   IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome [J].
Belloni, Laura ;
Allweiss, Lena ;
Guerrieri, Francesca ;
Pediconi, Natalia ;
Volz, Tassilo ;
Pollicino, Teresa ;
Petersen, Joerg ;
Raimondo, Giovanni ;
Dandri, Maura ;
Levrero, Massimo .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (02) :529-537
[7]   Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation [J].
Bengsch, Bertram ;
Martin, Bianca ;
Thimme, Robert .
JOURNAL OF HEPATOLOGY, 2014, 61 (06) :1212-1219
[8]   HLA CLASS-I-RESTRICTED HUMAN CYTOTOXIC T-CELLS RECOGNIZE ENDOGENOUSLY SYNTHESIZED HEPATITIS-B VIRUS NUCLEOCAPSID ANTIGEN [J].
BERTOLETTI, A ;
FERRARI, C ;
FIACCADORI, F ;
PENNA, A ;
MARGOLSKEE, R ;
SCHLICHT, HJ ;
FOWLER, P ;
GUILHOT, S ;
CHISARI, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10445-10449
[9]   Adaptive immunity in HBV infection [J].
Bertoletti, Antonio ;
Ferrari, Carlo .
JOURNAL OF HEPATOLOGY, 2016, 64 :S71-S83
[10]   Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection [J].
Blattman, Joseph N. ;
Wherry, E. John ;
Ha, Sang-Jun ;
van der Most, Robbert G. ;
Ahmed, Rafi .
JOURNAL OF VIROLOGY, 2009, 83 (09) :4386-4394